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The term autophagy refers to a group of catabolic pathways that deliver cytoplasmic constituents 
for lysosomal degradation [1]. One of these, macroautophagy, has been shown to both degrade 
some pathogens and promote the replication of others [2]. In the case of Chikungunya virus 
(CHIKV) infection, it had been reported to promote replication in humans and restrict it in mice 
[3, 4]. This discrepancy and its molecular underpinnings have now been resolved in a study from 
the Lecuit group, published in this issue of EMBO reports [5], which also provides a strategy to 
generate a better mouse model to study Chikungunya fever.  
 
 
Macroautophagy — the best studied of the autophagic pathways— can engulf cell organelles or 
protein aggregates into double-membrane surrounded vesicles, so-called autophagosomes, 
which then fuse with lysosomes. Substrate selection into these autophagosomes is achieved by 
binding to the essential autophagy protein Atg8 (autophagy-related gene 8) or its mammalian 
homologues MAP1LC3A-C (microtubule-associated protein 1 light chain 3 A-C) and 
GABARAP1-2 (GABA-receptor associated protein 1-2), which are attached in an ubiquitin-like 
reaction to the autophagosomal membrane. LC3 binds to LC3 interacting motifs (LIRs) present 
either directly in cargo proteins, in anchor proteins that also contain an ubiquitin binding domain 
(UBA) to recruit ubiquitinated proteins, or through detection of cytosol exposed glycosylation 
from damaged vesicles [1, 6]. All of the four known macroautophagy anchor proteins, 
p62/sequestosome-1, NBR1 (neighbor of BRCA1 gene 1), NDP52 (nuclear dot protein 52) and 
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optineurin, can also recruit pathogens to autophagosomes during innate or cell intrinsic immunity 
[6].  
 This innate restriction allows lysosomal targeting of pathogens that have escaped from 
endosomes into the cytosol or that are contained in damaged vesicles [6]. Among these, 
neurotropic infections with Sindbis and Herpes simplex virus (HSV) have been investigated [7, 
8]. HSV encodes ICP34.5, a protein that inhibits macroautophagy by binding to its molecular 
machinery. Mutant HSV lacking this protein is impaired in its ability to cause lethal encephalitis, 
presumably because it is more efficiently degraded by macroautophagy. Similarly, Sindbis virus 
capsids are recruited to autophagosomes through p62/sequestosome-1, and Sindbis virus 
replication is enhanced in macroautophagy-deficient cells, leading to lethal central nervous 
system infection. The ubiquitination of Sindbis virus and HSV capsids for recruitment into 
autophagosomes might be mediated by the SMURF1 ubquitin ligase [9]. In contrast to these 
anti-viral functions of macroautophagy, its core machinery seems to also support the replication 
of some viruses and is even stimulated by them. This was for example shown for poliovirus, 
hepatitis C virus (HCV) and human immunodeficiency virus (HIV) [6]. Some viruses seem to 
manipulate macroautophagy to assemble membrane compartments on which they replicate, as 
is the case for poliovirus and HCV, whereas others use the autophagic core machinery to 
efficiently egress from cells after replication, as shown for HIV and suggested for poliovirus. In 
the latter case, the autophagic membranes are stabilized by the viruses and prevented from 
fusion with lysosomes. Indeed, a number of viral proteins that inhibit fusion of autophagosomes 
with lysosomes have been identified, including the spike complex of Semliki Forest virus, the Nef 
protein of HIV and the M2 protein of influenza A virus [6]. Therefore, the macroautophagy 
machinery can mediate pro-viral and anti-viral functions, and the fate of the membranes to which 
it recruits viral components seems to determine if viral restriction or replication is supported. 
 Infection with CHIKV —which, as Sindbis and Semliki Forest virus, belongs to the 
alphavirus genus— exemplifies these pro- and anti-viral functions. Macroautophagy has been 
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reported to protect mice from lethality by CHIKV infection [4], probably by limiting infection-
induced cell death, which promotes viral replication. On the other hand, the macroautophagy 
machinery promotes viral replication in human kidney epithelial cells [3]. Now, Judith and 
colleagues demonstrate in primary and immortalized human cells that CHIKV engages the 
molecular machinery of macroautophagy at different sites. Ubiquitinated viral capsids are 
degraded by lysosomes after recruitment into autophagosomes through p62/sequestosome-1 
binding to LC3B. This protective function of macroautophagy could be observed in both human 
and mouse cells. By contrast, only in human cells the viral non-structural protein 2 (nsP2) binds 
NDP52 and co-localizes with LC3C on trans-Golgi membranes, promoting viral replication. This 
pro-viral role of the macroautophagy machinery can be transferred to mouse cells by 
transfection of human NDP52 and LC3C. This study suggests that NDP52 mediates a pro-viral 
and p62/sequestosome-1 an anti-viral effect during CHIKV infection and only the anti-viral effect 
is conserved in mouse cells. This implies that the mouse model of CHIKV infection could be 
improved by introducing human NDP52 and LC3C to elicit both the pro-viral and anti-viral 
functions of macroautophagy in vivo. 
 Such a model would especially useful to interrogate the functions of macroautophagy 
during CHIKV infection that are not cell intrinsic and affect the communication of infected cells 
with components of the immune system. Along these lines, the balance of replication and viral 
capsid degradation could influence the production of pro-inflammatory cytokines as well as 
antigen presentation [6]. In this respect, viral replication on the cytosolic surface of membranes 
could engage cytosolic RNA receptors, and viral capsid degradation could colocalize viral RNA 
with endosomal toll-like receptors (TLRs) —such as TLR7 and 8. Both pathways of pathogen-
associated molecular pattern recognition and the resulting cytokine production are known to be 
influenced by macroautophagy [2]. Furthermore, macroautophagy can deliver cytosolic antigens 
for processing and presentation by major histocompatibility complex (MHC) class II molecules to 
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amplify CD4+ T cell stimulation [6]. This antigen presentation could be augmented by enhanced 
replication and viral capsid degradation, both mediated by the macroautophagy machinery.  
 Thus, the study by Judith and colleagues in this issue of EMBO Reports both resolves 
the controversy on the role of macroautophagy in CHIKV infection and suggests a way to 
improve in vivo models for this viral infection with relevance to human disease. Notably, such 
improvements on the in vivo infection model for CHIKV fever would be timely for this re-
emerging viral disease, and would allow investigating new treatment options, required to 
suppress this disease in its endemic areas and prevent further spreading —such as the recent 
outbreak in Italy [10]. More generally, it also argues that pathogens should be always studied in 
cells of the original host species or the species in which they cause disease, at least in parallel 
with cells of other origin, because their adaptation to influence cellular pathways has often 
exquisitely evolved with this particular species.  
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Figure legend 
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Figure 1: The molecular machinery of macroautophagy supports and restricts CHIKV 
replication in human cells. NDP52 recruits nsP2 to the trans-Golgi-network by binding to 
membrane anchored LC3C. This seems to facilitate the assembly of the CHIKV replication 
complex at these sites and supports viral replication. Some of the CHIKV capsids produced as a 
result are ubiquitinated and bind to LC3B on autophagosomal membranes through 
p62/sequestosome-1. Autophagosomes then deliver these capsids for lysosomal degradation, 
leading to restriction of viral replication. 
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